Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)
Clinical trial NCT00694356 · COMPLETED
Trial details
- NCT number
- NCT00694356
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-04
- Primary completion
- 2009-03-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.